MGRM vs. BWAY, PDEX, NVNO, ICCM, AMIX, SRTS, BLUA, NSPR, HSAQ, and KRMD
Should you be buying Monogram Orthopaedics stock or one of its competitors? The main competitors of Monogram Orthopaedics include BrainsWay (BWAY), Pro-Dex (PDEX), enVVeno Medical (NVNO), IceCure Medical (ICCM), Autonomix Medical (AMIX), Sensus Healthcare (SRTS), BlueRiver Acquisition (BLUA), InspireMD (NSPR), Health Sciences Acquisitions Co. 2 (HSAQ), and KORU Medical Systems (KRMD). These companies are all part of the "surgical & medical instruments" industry.
Monogram Orthopaedics (NASDAQ:MGRM) and BrainsWay (NASDAQ:BWAY) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, media sentiment, community ranking, institutional ownership and valuation.
In the previous week, BrainsWay had 1 more articles in the media than Monogram Orthopaedics. MarketBeat recorded 2 mentions for BrainsWay and 1 mentions for Monogram Orthopaedics. BrainsWay's average media sentiment score of -0.50 beat Monogram Orthopaedics' score of -1.00 indicating that BrainsWay is being referred to more favorably in the news media.
BrainsWay has a consensus price target of $7.00, indicating a potential upside of 47.06%. Given BrainsWay's higher probable upside, analysts clearly believe BrainsWay is more favorable than Monogram Orthopaedics.
Monogram Orthopaedics has a net margin of 0.00% compared to BrainsWay's net margin of -13.20%. BrainsWay's return on equity of -10.05% beat Monogram Orthopaedics' return on equity.
BrainsWay received 60 more outperform votes than Monogram Orthopaedics when rated by MarketBeat users.
BrainsWay has higher revenue and earnings than Monogram Orthopaedics. BrainsWay is trading at a lower price-to-earnings ratio than Monogram Orthopaedics, indicating that it is currently the more affordable of the two stocks.
0.5% of Monogram Orthopaedics shares are held by institutional investors. Comparatively, 30.1% of BrainsWay shares are held by institutional investors. 32.1% of Monogram Orthopaedics shares are held by insiders. Comparatively, 19.0% of BrainsWay shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
BrainsWay beats Monogram Orthopaedics on 11 of the 15 factors compared between the two stocks.
Get Monogram Orthopaedics News Delivered to You Automatically
Sign up to receive the latest news and ratings for MGRM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MGRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Monogram Orthopaedics Competitors List
Related Companies and Tools
